Skip to main content

Table 1 Baseline characteristics

From: Improvement of microcirculatory impairment in patients with predialysis chronic kidney disease after AST-120 administration

Age (year)

74.0 ± 7.6

Male/Female, N

23:07

BMI (kg/m2)

22.7 ± 3.0

Blood pressure, mmHg

 Systolic

129.5 ± 14.6

 Diastolic

73.6 ± 10.0

Underlying disease, N (%)

 Glomerulonephritis

25

 Others or unknown

5

CKD stage, N (%)

 G3a

4 (13.3)

 G3b

9 (30.0)

 G4

14 (46.7)

 G5

3 (10.0)

Comorbidity, N (%)

 Hypertension

25 (83.3)

 Dyslipidemia

23 (76.7)

 Ischemic heart disease

3 (10.0)

 Aortic aneurysm

1 (3.3)